SCHEMBL6181966

SCHEMBL6181966

CC(CCCCCCCCCCCC(C)(CC(O)O)c1ccccc1)(CC(=O)O)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.60
HIF1A Q16665 1/20 0.60
FFAR1 O14842 1/20 0.40
CPT2 P23786 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
RIPK1 Q13546 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 2/20 0.34
KMT2A Q03164 2/20 0.34
KIF11 P52732 5/20 0.33
ALDH1A1 P00352 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19160082 0.85 CYP2C19 (0.60) CYP2C19HIF1AFFAR1CPT2TDP1
SCHEMBL2737150 0.85 CYP2C19 (0.60) CYP2C19HIF1AFFAR1CPT2TDP1
SCHEMBL12094505 0.84 CYP2C19 (0.62) CYP2C19HIF1AFFAR1CPT2TDP1
SCHEMBL12094514 0.83 CYP2C19 (0.66) CYP2C19HIF1AFFAR1CPT2TDP1
SCHEMBL3280386 0.82 CYP2C19 (0.64) CYP2C19HIF1AFFAR1CPT2TDP1
SCHEMBL7021873 0.81 CYP2C19 (0.39) CYP2C19HIF1ARIPK1CYP1A2CYP2D6
SCHEMBL7027201 0.81 CYP2C19 (0.39) CYP2C19HIF1ARIPK1CYP1A2CYP2D6
SCHEMBL7027006 0.81 CYP2C19 (0.39) CYP2C19HIF1ARIPK1CYP1A2CYP2D6
SCHEMBL7027001 0.81 CYP2C19 (0.40) CYP2C19HIF1AMAPTKMT2AKIF11
SCHEMBL3286672 0.80 CYP2C19 (0.66) CYP2C19HIF1AFFAR1CPT2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1597223-A2 HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2005-11-23 EP disclosed
WO-2004067489-A2 HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2004-08-12 WO disclosed